Patents Assigned to GreenStone Biosciences, Inc.
  • Dihydroartemisinin derivatives and the treatment of fibrotic diseases
    Publication number: 20250051350
    Abstract: Compounds of formulae PT-1, PT-2, PT-4, PT-13, PT-14, PT-20, PT-23 to PT-25, and PT-27 to PT-30, and their salts, pharmaceutical formulations containing them, and the use of these derivatives for the treatment of fibrotic diseases.
    Type: Application
    Filed: July 18, 2024
    Publication date: February 13, 2025
    Applicant: GreenStone Biosciences, Inc.
    Inventors: Joseph C. Wu, Honit Piplani, Hao Zhang, Rabindra Vishwadev Shivnaraine, Christopher David Yan
  • Treatment of the adverse cardiovascular effects of cannabinoids
    Publication number: 20240307342
    Abstract: Treatment of the adverse cardiovascular effects of cannabinoids in a subject with genistein or a genistein derivative.
    Type: Application
    Filed: April 26, 2023
    Publication date: September 19, 2024
    Applicant: GreenStone Biosciences, Inc.
    Inventors: Joseph C Wu, Jade Chao, Mark Chandy, Paul Pang
  • Combination treatment of dilated cardiomyopathy
    Publication number: 20230321077
    Abstract: Treatment of dilated cardiomyopathy in a subject by combination treatment with a tyrosine kinase inhibitor and a statin.
    Type: Application
    Filed: April 10, 2023
    Publication date: October 12, 2023
    Applicant: GreenStone Biosciences, Inc.
    Inventors: Joseph C. Wu, Chun Liu, Christopher David Yan, Celine Lai